TPD & Induced Proximity Summit Leaderboard
  • Sunday, June 21, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 45

Author

Pharma Journalist 8887 posts 0 comments

UCB Secures FDA Approval for KYGEVVI, the First-Ever Treatment for Ultra-Rare TK2 Deficiency

Nov 4, 2025
UCB, a global biopharmaceutical company, has received U.S. Food and Drug Administration (FDA) approval for KYGEVVI, a treatment for adults and pediatric patients suffering from…
Read More...

IntoCell and Xcellon Biologics Partner to Advance Next-Generation ADC Development and Manufacturing

Nov 4, 2025
IntoCell Inc., a biotechnology company specializing in next-generation payload and linker technologies for antibody–drug conjugates (ADCs), has entered into a strategic collaboration…
Read More...

Helex Raises $3.5 Million Seed Round to Advance Gene Therapy for Genetic Kidney Diseases

Oct 31, 2025
Helex, a biotechnology company developing targeted therapies for genetic kidney diseases, has announced the completion of an oversubscribed $3.5 million Seed round led by pi Ventures,…
Read More...

FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ First-in-Class Gastric Cancer Drug

Oct 31, 2025
Dewpoint Therapeutics, a biotechnology company pioneering condensate biology, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to…
Read More...

Eli Lilly to Invest $1.2 Billion in Puerto Rico Manufacturing Expansion

Oct 31, 2025
Eli Lilly and Company announced plans to invest over $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico, strengthening its U.S.…
Read More...

Novo Nordisk Makes $6.5 Billion Unsolicited Bid to Acquire Biotech Firm Metsera

Oct 31, 2025
Novo Nordisk has confirmed submitting an unsolicited proposal to acquire U.S.-based Metsera, Inc., a biotechnology company developing early- and mid-stage incretin and non-incretin…
Read More...

Debiopharm and NetTargets Partner to Develop AI-Driven Dual-Payload Cancer Therapies

Oct 31, 2025
Swiss biopharmaceutical company Debiopharm has entered into a strategic research collaboration with South Korea–based biotech firm NetTargets to accelerate the discovery of novel,…
Read More...

Seres Therapeutics Receives $3.6 Million CARB-X Grant to Develop Liquid Form of SER-155 for…

Oct 30, 2025
Seres Therapeutics, Inc. announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has awarded the company up to $3.6 million in additional…
Read More...

FDA Moves to Streamline Biosimilar Development, Cut Costs and Speed Access to Affordable Biologic…

Oct 30, 2025
The U.S. Food and Drug Administration (FDA) has unveiled a new draft guidance aimed at making the development of biosimilar medicines—lower-cost alternatives to expensive biologic…
Read More...

AI in Drug Discovery 2026: Novo Nordisk’s Peter Clark to Chair Landmark Event Driving AI Integration…

Oct 30, 2025
London, UK – 30 October 2025 – SAE Media Group has officially unveiled the agenda for the 7th Annual AI in Drug Discovery conference, taking place 9–10 March 2026 at the Hilton London…
Read More...
Prev Next
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Voro and Alloy Partner on Safer Cancer Immunotherapies
  • uniQure Reports Early Promise for Epilepsy Gene Therapy
  • Boltz and Takeda Expand AI-Powered Drug Discovery Efforts
  • SK Pharmteco Partners With OTXL for Rare Disease Therapies
  • Next-Generation GLP-1 Therapies Are Reshaping the Future of Obesity Treatment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.